Alveus Therapeutics’ Phase 2-ready lead drug hits the same two targets as Amgen’s MariTide, but with the potential for a dosing advantage. The startup’s pipeline
Ventyx Biosciences’ lead program, an oral small molecule inhibitor of NLRP3, has encouraging clinical data from separate mid-stage tests in cardiovascular disease and Parkinson’s disease.
Those who act first will lower cost to serve, boost rep productivity and deliver customer experiences that feel personal, not programmatic. Those who wait risk
While there is a significant need and opportunity to address this overall spend with advanced AI tools that predict patient needs and readmission likelihood, intrinsic
[Sponsored] This webinar will explore how technology will play a key role in the future of improving medical billing. The post Healthcare Revenue Cycle Transformation:
Color Health is partnering with insurer Evry Health to offer its virtual cancer clinic to employer health plan members. The post Color Health Partners With
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.
